Worm M, Thyssen JP, Schliemann S, Bauer A, et al. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial. Br J Dermatol 2022;187:42-51.
PMID: 35084738